CRIS
Curis Inc
NASDAQ: CRIS · HEALTHCARE · BIOTECHNOLOGY
$0.60
+6.88% today
Updated 2026-04-30
Market cap
$23.79M
P/E ratio
—
P/S ratio
2.52x
EPS (TTM)
$-0.58
Dividend yield
—
52W range
$0 – $3
Volume
0.5M
Curis Inc (CRIS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-80.30%
Operating margin
-665.00%
ROE
-2,951.00%
ROA
-67.20%
Debt/equity
-2.08x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $14.94M | $-8.83M | 100.00% | -67.32% | -59.12% |
| 2007 | $16.39M | $-6.96M | 100.00% | -51.10% | -42.49% |
| 2008 | $8.37M | $-12.12M | 100.00% | -156.81% | -144.90% |
| 2009 | $8.59M | $-9.82M | 100.00% | -116.94% | -114.35% |
| 2010 | $16.00M | $-4.44M | 100.00% | -35.24% | -27.72% |
| 2011 | $14.76M | $-9.86M | 100.00% | -48.79% | -66.78% |
| 2012 | $16.97M | $-16.42M | 98.96% | -109.71% | -96.73% |
| 2013 | $15.00M | $-12.32M | 98.68% | -62.77% | -82.14% |
| 2014 | $9.84M | $-18.73M | 96.55% | -161.14% | -190.27% |
| 2015 | $7.88M | $-58.98M | 94.85% | -716.91% | -748.64% |
| 2016 | $7.53M | $-60.41M | 94.70% | -771.08% | -802.59% |
| 2017 | $9.90M | $-53.32M | 94.99% | -502.73% | -538.66% |
| 2018 | $10.43M | $-32.58M | 94.60% | -281.29% | -312.38% |
| 2019 | $10.00M | $-32.14M | 94.97% | -243.46% | -321.28% |
| 2020 | $10.84M | $-29.91M | 95.07% | -229.79% | -276.03% |
| 2021 | $10.65M | $-45.44M | 94.99% | -395.01% | -426.67% |
| 2022 | $10.16M | $-60.32M | 97.47% | -521.75% | -593.62% |
| 2023 | $10.02M | $-47.41M | 100.00% | -482.21% | -473.04% |
| 2024 | $10.91M | $-43.39M | 99.10% | -408.34% | -397.77% |
| 2025 | $9.44M | $-7.58M | 99.52% | -348.43% | -80.29% |